
Keywords: αCD44; anti-CD44 antibody; bTyr-NSP; biotinylated tyrosine-derived nanospheres; bTyr-NSP-PTX; biotinylated tyrosine-derived nanospheres loaded with paclitaxel; CTAB; cetyltrimethylammonium bromide; ESA; epithelial-specific antigen; DCC; N,Nâ²-dicyclohex